Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 2.77M | 2.84M | +67.3K (+2.4%) |
| Value | $7.43M | $13.2M | +$5.80M (+78.1%) |
New holders (7)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 82,920 | $387.0K | 0.00% |
| Marshall Wace, LLP | 79,836 | $373.0K | 0.00% |
| State Street Corp | 65,790 | $307.0K | 0.00% |
| Two Sigma Advisers, LP | 36,500 | $170.0K | 0.00% |
| Two Sigma Securities, LLC | 22,354 | $104.0K | 0.02% |
| Arrowstreet Capital, Limited Partnership | 21,238 | $99.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 20,200 | $94.0K | 0.00% |
Sold out (4)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 12,021 | $32.0K |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $27.0K |
| Russell Investments Group, Ltd. | 5,198 | $13.0K |
| UBS Group AG | 1,933 | $5.00K |